Drug Patents and intellectual rights


Intellectual property rights (IPR) have been defined as Discovery, inventions, and creative expressions based on which there is a public willingness to attach the status of the property. IPR provides certain exclusive rights to the inventors or creators of that property, in order to enable them to earn commercial benefits from their creative efforts or reputation. There are several types of intellectual property protection like patent, copyright, trademark, etc. A patent is recognition for an invention, which satisfies the criteria of global novelty, non-obviousness, and industrial application. IPR is a prerequisite for better identification, planning, commercialization, rendering, and thereby protection of invention or creativity. Each industry should evolve its own IPR policies, management style, strategies, and so on depending on its area of specialty. The pharmaceutical industry currently has an evolving IPR strategy requiring a better focus and approach in the coming era. Usually, the patent in the Drug market is for 20 years, after that generic drug can be developed and made available to the patient in fewer prices

Keywords: Drug, intellectual property, license, patent, pharmaceutical

Subtracks

  1. Types of Intellectual Properties and their Description
  2. Role of Undisclosed Information in Intellectual Property
  3. Rationale of Patent
  4. Rationale of License
  5. The Role of Patent Cooperation Treaty
  6. Management of Intellectual Property in Pharmaceutical Industries
  7. Special Aspects of Drug Patent Specification

 

 


 


    Related Conference of Drug Patents and intellectual rights

    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    August 27-28, 2025

    20th World Congress on Drug Formulation & Drug Delivery

    Amsterdam, Netherlands
    September 19-20, 2025

    18th World Drug Delivery Summit

    Paris, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 24-25, 2025

    5th World Congress on Rare Diseases & Orphan Drugs

    Aix-en-Provence, France
    October 23-24, 2025

    21st Annual Meet on Pharmaceutical Sciences

    Aix-en-Provence, France
    November 11-12, 2025

    6th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 01-02, 2025

    13th International Conference on Clinical Trials

    Vancouver, Canada
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, Aland Islands
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 21-22, 2026

    8th International Conference and Exhibition on Pain Management

    Aix-en-Provence, France

    Drug Patents and intellectual rights Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in